Chumakov, A M; Grillier, I; Chumakova, E et al. (1997) Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor. Mol Cell Biol 17:1375-86
|
Gombart, A F; Yang, R; Campbell, M J et al. (1997) Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A. Leukemia 11:1673-80
|
Mori, N; Morosetti, R; Lee, S et al. (1997) Allelotype analysis in the evolution of chronic myelocytic leukemia. Blood 90:2010-4
|
Hirama, T; Miller, C W; Wilczynski, S P et al. (1996) p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines. Mod Pathol 9:26-31
|
Hatta, Y; Hirama, T; Miller, C W et al. (1995) Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 85:2699-704
|
Kizaki, M; Sakashita, A; Karmakar, A et al. (1993) Regulation of manganese superoxide dismutase and other antioxidant genes in normal and leukemic hematopoietic cells and their relationship to cytotoxicity by tumor necrosis factor. Blood 82:1142-50
|
Kizaki, M; Ikeda, Y; Simon, K J et al. (1993) Effect of 1,25-dihydroxyvitamin D3 and its analogs on human immunodeficiency virus infection in monocytes/macrophages. Leukemia 7:1525-30
|
Chumakov, A; Koeffler, H P (1993) Specific interaction between adenoviral 55-kDa E1B protein and in vivo produced p53 fusion proteins. Gene 131:231-6
|
Paquette, R L; Lee, Y Y; Wilczynski, S P et al. (1993) Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 72:1272-80
|
Paquette, R L; Koeffler, H P (1992) Differentiation therapy. Hematol Oncol Clin North Am 6:687-706
|
Showing the most recent 10 out of 14 publications